Literature DB >> 8473009

Interferon-gamma-activated monocytes impair infectivity of HIV particles by an oxygen metabolite-dependent reaction.

J Ennen1, R Kurth.   

Abstract

Mononuclear phagocytes generate microbicidal oxygen metabolites spontaneously and after phagocytic stimulation by a NADPH-dependent enzymatic reaction called the oxidative burst. The spontaneous release of reactive oxygen radicals and intermediates (ROI) increases five- to eightfold after treatment of monocytes with the lymphokine interferon-gamma (IFN-gamma). The effect of the IFN-gamma-activated release of ROI by human monocytes on the infectivity of free human immunodeficiency virus (HIV) in the supernatant was investigated with the following results. First, IFN-gamma-activated, but neither control monocytes nor lipopolysaccharide-stimulated monocytes effectively decreased the infectivity of cell-free HIV-1 in culture medium supernatant. Second, the mechanism of inactivation was dependent on the enhanced spontaneous release of ROI by IFN-gamma-activated mononuclear phagocytes, since either the enzyme catalase or the free radical scavenger butylated hydroxyanisole (BHA) could block this activity. Third, soluble and solid-phase HIV-1 outer envelope glycoprotein (gp120) failed to trigger the oxidative burst activity after specific gp120-monocytic CD4 receptor interaction. These results indicate an anti-viral effect of IFN-gamma-activated monocytes/macrophages on HIV-1 which may have important implications for our understanding of spread of the virus in the body and the development of full-blown AIDS after a long period of latency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473009      PMCID: PMC1421807     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  Degradation of microorganisms by phagocytic cells.

Authors:  P Elsbach
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

2.  Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro.

Authors:  J Ennen; I Seipp; S G Norley; R Kurth
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

3.  Mutational analysis of the simian immunodeficiency virus SIVmac nef gene.

Authors:  D Binninger; J Ennen; D Bonn; S G Norley; R Kurth
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys.

Authors:  S Hartung; K Boller; K Cichutek; S G Norley; R Kurth
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives.

Authors:  S Mihm; J Ennen; U Pessara; R Kurth; W Dröge
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

6.  Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells.

Authors:  J M Molina; D T Scadden; C Amirault; A Woon; E Vannier; C A Dinarello; J E Groopman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

8.  Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.

Authors:  H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

9.  Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.

Authors:  H W Murray; C W Juangbhanich; C F Nathan; Z A Cohn
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi.

Authors:  C Nathan; N Nogueira; C Juangbhanich; J Ellis; Z Cohn
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  1 in total

1.  Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211).

Authors:  W T Shearer; M W Kline; S L Abramson; T Fenton; S E Starr; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.